A decade after blockbuster $49.9 billion merger, former leaders say Minnesota-run medtech maker facing innovation reckoning.
The aging of America’s population represents a historic moment to create an institutional and cultural infrastructure for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback